| | | Richard E. Gammans , Ph.D. Chief Development Officer Dr. Gammans has more than 25 years experience in drug discovery and development. Most... | | Ms. Schilberg has more than 20 years experience in the life sciences. Under her leadership, BioAdvance has invested over $11.5 million in 21... | |